GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » Asset Turnover

THC Therapeutics (THC Therapeutics) Asset Turnover

: 0.00 (As of Jul. 2023)
View and export this data going back to 2007. Start your Free Trial

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. THC Therapeutics's Revenue for the three months ended in Jul. 2023 was $0.00 Mil. THC Therapeutics's Total Assets for the quarter that ended in Jul. 2023 was $0.01 Mil. Therefore, THC Therapeutics's Asset Turnover for the quarter that ended in Jul. 2023 was 0.00.

Asset Turnover is linked to ROE % through Du Pont Formula. THC Therapeutics's annualized ROE % for the quarter that ended in Jul. 2023 was 4.01%. It is also linked to ROA % through Du Pont Formula. THC Therapeutics's annualized ROA % for the quarter that ended in Jul. 2023 was -1,015.38%.


THC Therapeutics Asset Turnover Historical Data

The historical data trend for THC Therapeutics's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Asset Turnover
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

THC Therapeutics Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Asset Turnover Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


THC Therapeutics Asset Turnover Distribution

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's Asset Turnover distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's Asset Turnover falls into.



THC Therapeutics Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

THC Therapeutics's Asset Turnover for the fiscal year that ended in Jul. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jul. 2023 )/( (Total Assets (A: Jul. 2022 )+Total Assets (A: Jul. 2023 ))/ count )
=0/( (0.207+0.013)/ 2 )
=0/0.11
=0.00

THC Therapeutics's Asset Turnover for the quarter that ended in Jul. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jul. 2023 )/( (Total Assets (Q: Apr. 2023 )+Total Assets (Q: Jul. 2023 ))/ count )
=0/( (0.013+0.013)/ 2 )
=0/0.013
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


THC Therapeutics  (OTCPK:THCT) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

THC Therapeutics's annulized ROE % for the quarter that ended in Jul. 2023 is

ROE %**(Q: Jul. 2023 )
=Net Income/Total Stockholders Equity
=-0.132/-3.2935
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.132 / 0)*(0 / 0.013)*(0.013/ -3.2935)
=Net Margin %*Asset Turnover*Equity Multiplier
= %*0*-0.0039
=ROA %*Equity Multiplier
=-1,015.38 %*-0.0039
=4.01 %

Note: The Net Income data used here is four times the quarterly (Jul. 2023) net income data. The Revenue data used here is four times the quarterly (Jul. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

THC Therapeutics's annulized ROA % for the quarter that ended in Jul. 2023 is

ROA %(Q: Jul. 2023 )
=Net Income/Total Assets
=-0.132/0.013
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.132 / 0)*(0 / 0.013)
=Net Margin %*Asset Turnover
= %*0
=-1,015.38 %

Note: The Net Income data used here is four times the quarterly (Jul. 2023) net income data. The Revenue data used here is four times the quarterly (Jul. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


THC Therapeutics Asset Turnover Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


THC Therapeutics (THC Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135
Website
THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.
Executives
Hiro Tanaka director, officer: Vice President 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R director, officer: Chair of the Board 119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann director, 10 percent owner, officer: CEO, CFO 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho director, officer: CEO 701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX

THC Therapeutics (THC Therapeutics) Headlines